Differentials

Benign renal cyst

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Typically asymptomatic.

INVESTIGATIONS

Bosniak classification on imaging: low score (if questionable, interval change on imaging and/or pathology is distinguishing).[69]

Ureteric cancer

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Visible (gross) hematuria more common.

INVESTIGATIONS

Ureteroscopy: ureteric mass.

Bladder cancer

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Visible (gross) hematuria more common. Dysuria.

INVESTIGATIONS

Urine cytology: positive in up to 90% of patients with carcinoma in situ or high-grade tumors; positive in <33% of patients with low-grade transitional cell cancer.

Upper urinary tract urothelial tumor

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Visible (gross) hematuria more common.

INVESTIGATIONS

Gross pathology: transitional cell carcinoma histology.

Ureteroscopy: central renal mass (pelvis).

MRI: central pelvic/urethral location of mass.

Angiomyolipoma

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically indistinguishable.

Often too small to present with palpable masses, and usually asymptomatic. May grow to cause pain and hematuria.

INVESTIGATIONS

CT/MRI: small (<1 cm); characteristic features (particular fat distribution). If questionable on imaging, and especially if 1-3 cm in size, percutaneous biopsy indicated.[69]

Oncocytoma

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinically indistinguishable.

Typically asymptomatic; often small.

INVESTIGATIONS

CT/MRI: small (1-3 cm), may have characteristic features (almost always solid, and nonenhancing). If questionable on imaging, percutaneous biopsy may be indicated.[69]

Secondary metastases

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Symptoms consistent with other primary tumors may point toward secondary metastatic renal lesions. Symptoms from local disease burden less likely (the masses are generally smaller but multifocal).[68]

INVESTIGATIONS

Presence of nonrenal malignancy on any diagnostic test with nonenhancing renal masses makes metastases more likely, but if no progression of nonrenal primary cancer documented, there is less chance of renal metastases.[68][73]

Congenital renal parenchymal abnormalities

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Often no distinguishing symptoms or signs.

INVESTIGATIONS

CT and MRI (especially the latter) can usually help distinguish.

Renal infarction

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinical history of vascular risk factors may raise suspicion of infarction (especially poorly controlled hypertension/hypertensive crisis).

INVESTIGATIONS

MRI: assesses kidney and determines likelihood of infarction.

Magnetic resonance angiogram: assesses local vessels.

Renal infection

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Clinical history of fever or sepsis.

INVESTIGATIONS

CBC: leukocytosis.

Blood culture: bacteremia. Urine culture: bacteriuria.

Serial imaging (CT/MRI) may be needed to ensure resolution of renal mass after treatment for infection.

Use of this content is subject to our disclaimer